哪种18F-FDG PET疗效评估标准最能预测NSCLC根治性放化疗后的生存
研究比较EORTC、PERCIST 1.0、Peter Mac代谢视觉标准和Deauville标准在非小细胞肺癌根治性放化疗后18F-FDG PET疗效评估中对总生存的预测价值,纳入87例患者,随访PET/CT中位89天。四种标准均与总生存显著相关,Peter Mac和Deauville视觉标准观察者间一致性更高、区分完全代谢缓解与非完全代谢缓解的能力更强。
要点
- 四种18F-FDG PET疗效标准均与NSCLC根治性放化疗后总生存显著相关。
- Peter Mac和Deauville视觉标准的观察者间一致性κ值分别为0.87和0.84,高于EORTC和PERCIST的0.76。
- 视觉标准在区分完全代谢缓解与非完全代谢缓解方面优于EORTC和PERCIST。
核心结论
- 四种疗效评估标准均高度预测总生存,但视觉标准观察者间一致性更高且区分完全代谢缓解与非完全代谢缓解能力更强,凸显视觉评估识别放射性肺炎、肺构型变化和缓解模式的重要性。
研究设计与样本
- 研究整合2004至2016年间开展的三项前瞻性放化疗试验,均包含基线和治疗后18F-FDG PET/CT显像。
- 共87例非小细胞肺癌患者在接受根治性放化疗前后行18F-FDG PET/CT,随访PET/CT在中位89天(四分位距79-93天)进行。
- 疗效分为完全代谢缓解、部分代谢缓解、代谢稳定疾病和代谢进展疾病,采用Cox比例风险模型和log-rank检验评估各标准疗效与总生存的关系。
主要发现
- PET疗效显像后中位随访49个月,中位总生存28个月。
- EORTC、PERCIST、Peter Mac和Deauville标准的观察者间一致性κ值分别为0.76、0.76、0.87和0.84。
- 四种疗效标准均与总生存显著相关。
- Peter Mac和Deauville标准拟合优于EORTC和PERCIST,且更好区分完全代谢缓解与非完全代谢缓解。
关键数值与推荐
- EORTC标准观察者间一致性κ=0.76。
- PERCIST 1.0标准观察者间一致性κ=0.76。
- Peter Mac代谢视觉标准观察者间一致性κ=0.87。
- Deauville标准观察者间一致性κ=0.84。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The optimal methodology for defining response with 18F-FDG PET after curative-intent chemoradiation for non-small cell lung cancer (NSCLC) is unknown. We compared survival outcomes according to the criteria of the European Organization for Research and Treatment of Cancer (EORTC), PERCIST 1.0, the Peter Mac metabolic visual criteria, and the Deauville criteria, respectively. Methods: Three prospective trials of chemoradiation for NSCLC, involving baseline and posttreatment 18F-FDG PET/CT imaging, were conducted between 2004 and 2016. Responses were categorized as complete metabolic response (CMR), partial metabolic response, stable metabolic disease, or progressive metabolic disease. Cox proportional-hazards models and log-rank tests assessed the impact of each response on overall survival (OS). Results: Eighty-seven patients underwent 18F-FDG PET/CT before and after radical chemoradiation for NSCLC. Follow-up 18F-FDG PET/CT scans were performed at a median of 89 d (interquartile range, 79-93 d) after radiotherapy. Median follow-up and OS after PET response imaging were 49 and 28 mo, respectively. Interobserver agreements for EORTC, PERCIST, Peter Mac, and Deauville had κ values of 0.76, 0.76, 0.87, and 0.84, respectively. All 4 response criteria were significantly associated with OS. Peter Mac and Deauville showed better fit than EORTC and PERCIST and distinguished better between CMR and non-CMR. Conclusion: All 4 response criteria were highly predictive of OS, but visual criteria showed greater interobserver agreement and stronger discrimination between CMR and non-CMR, highlighting the importance of visual assessment to recognize radiation pneumonitis, changes in lung configuration, and patterns of response.
引用
- Turgeon GA, Iravani A, Akhurst T, et al. What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria? J Nucl Med. 2018. PMID: 30030343. doi:10.2967/jnumed.118.214148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。